Sympathovagal imbalance in transsexual subjects

Journal of Endocrinological Investigation

Volumn 31, Issue 11, 2008, Pages 1014-1019

  Resmini, Eugenia ^a,c   Casu, M ^b   Patrone, V ^b   Rebora, A ^a   Murialdo, G ^b   Minuto, F ^a   Ferone, D ^a  

^a Department of Experimental Medicine (DIMES)   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Heart rate variability; Sympathovagal balance; Transsexual subjects

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN; SEX HORMONE; SPIRONOLACTONE;

ADRENERGIC TRANSMISSION; ADULT; ARTICLE; CHOLINERGIC TRANSMISSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE VARIABILITY; HORMONAL THERAPY; HUMAN; MALE; SPECTROSCOPY; STANDING; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; TRANSSEXUALISM; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 59849125917     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345641     Document Type: Article

References (30)

1. Malliani A, Lombardi F, Pagani M, Cerutti S. Power spectral analysis of cardiovascular variability in patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1994, 5: 274-86.
2. Vanoli E, Schwartz PJ. Sympathetic-parasympathetic interaction and sudden death. Basic Res Cardiol 1990, 85 (Suppl 1): 305-21.
3. Lombardi F, Malliani A, Pagani M, Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 1996, 32: 208-16.
4. Sosnowski M, Clark E, Latif S, Macfarlane PW, Tendera M. Heart rate variability fraction - a new reportable measure of 24 h R-R interval variation. Ann Noninvasive Elettrocardiol 2005, 10: 7-15.
5. Malliani A. Heart rate variability: from bench to bedside. Eur J Intern Med 2005, 16: 12-20.
6. Heart rate variability. Guidelines. Standards of measurements, physiological interpretation and clinical use. Task Force of the European society of Cardiology and The North American Society of Pacing and Electrophysiology. Eur Heart J 1996, 17: 354-81.
7. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Elettrocardiol 2005, 10: 88-101.
8. Spallone V, Uccioli L, Menzinger G. Diabetic autonomic neuropathy. Diabetes Metab Rev 1995, 11: 227-57.
9. Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Physician 2005, 71: 2123-8.
10. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care 2004, 27: 2942-7.
11. Resmini E, Casu M, Patrone V, et al. Sympathovagal imbalance in acromegalic patients. J Clin Endocrinol Metab 2006, 91: 115-20.
12. Evans JM, Ziegler MG, Patwardhan AR, et al. Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes. J Appl Physiol 2001, 91: 2611-8.
13. Stein PK, Kleiger RE, Rottman JN. Differing effects of age on heart rate variability in men and women. Am J Cardiol 1997, 80: 302-5.
14. Bonnemeier H, Richardt G, Potratz J, et al. Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. J Cardiovasc Electrophysiol 2003, 14: 791-9.
15. Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003, 285: H2188-93.
16. Rosano GM, Panina G. Oestrogens and the heart. Thérapie 1999, 54: 381-5.
17. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998, 351: 478-84.
18. Mortara A, La Rovere MT, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications Circulation 1997, 18: 3450-8.
19. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987, 75: 1102-9.
20. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results for the Women's Health Initiative randomized controlled trial. JAMA 2002, 288: 321-33.
21. Elbers JM, Giltay EJ, Teerlink T, et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 2003, 58: 562-71.
22. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991, 84: 482-92.
23. Cowan MJ. Measurement of heart rate variability. West J Nurs Res 1995, 17: 32-48.
24. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998, 32: 293-7.
25. Casolo GC, Stroder P, Signorini C, et al. Heart rate variability during the acute phase of myocardial infarction. Circulation 1992, 85: 2073-9.
26. Janszky I, Ericson M, Mittleman MA, et al. Heart rate variability in long-term risk assessment in middle-aged women with coronary heart disease: The Stockholm Female Coronary Risk Study. J Intern Med 2004, 255: 13-21.
27. Conte MR. Gender differences in the neurohumoral control of the cardiovascular system. Ital Heart J 2003, 4: 367-70.
28. Matsukawa T, Sugiyama Y, Watanabe T, Kobayashi F, Mano T. Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol 1998, 275: R1600-4.
29. Evans JM, Ziegler MG, Patwardhan AR, et al. Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes. J Appl Physiol 2001, 91: 2511-8.
30. Du XJ, Riemersma RA, Dart AM. Sex differences in the parasympathetic nerve control of rat heart. Clin Exp Pharmacol Physiol 1994, 21: 485-93.